NYC Agar Base was originally developed by Fauer, Weisburd and Wilson at the
New York City Department of Health for selective isolation of pathogenic
Neisseria species from clinical specimens. It consists of primarily a peptone-corn starch agar-base buffered with
phosphates and supplemented with horse
plasma, horse
haemoglobin,
dextrose,
yeast autolysate and
antibiotics. The transparent nature of the medium helps in studying the colonial types. Proteose peptone, horse plasma,
haemoglobin provide nutrients for the growth of
N. gonorrhoeae and
N. meningitidis.
Phosphate buffers the medium. The selective supplement added contains the antibiotics
vancomycin,
colistin,
nystatin and
trimethoprim, to suppress the accompanying flora.
Vancomycin is inhibitory for
gram-positive bacteria.
Colistin inhibits
gram negative bacteria, including
Pseudomonas species, while
Proteus is inhibited by
trimethoprim. The combination of
trimethoprim and
colistin acts
synergistically against
gram-negative bacilli.
Starch neutralizes the toxic metabolites produced by
Neisseria. The yeast autolysate supplement fulfils the requirements needed to enhance
Neisseria growth. Yeast contains
oxaloacetic acid which is metabolized by
gonococci to produce sufficient for growth of capnophilic gonococci. Also, presence of yeast autolysate reduces the
lag phase of growth of
Neisseria, thus enhancing both size and number of colonies. The specimen can be directly streaked on the medium to obtain maximum isolation. ==Procedure==